Pooled prevalence of blindness in Ethiopia: a systematic review and meta-analysis.

anterior chamber colour vision cornea epidemiology eye (globe) glaucoma low vision aid macula

Journal

BMJ open ophthalmology
ISSN: 2397-3269
Titre abrégé: BMJ Open Ophthalmol
Pays: England
ID NLM: 101714806

Informations de publication

Date de publication:
06 2022
Historique:
received: 13 12 2021
accepted: 17 05 2022
entrez: 26 9 2022
pubmed: 27 9 2022
medline: 28 9 2022
Statut: ppublish

Résumé

Blindness is defined as presenting visual acuity worse than 3/60 in the better eye. Its highest proportion has been conforming to the developing countries such as Ethiopia. So, timely information is crucial to design strategies. However, the study on the magnitude of blindness in Ethiopia was outdated which means it was conducted in 2005-2006. Therefore, this study was proposed to estimate the pooled prevalence of blindness in Ethiopia.Databases like PubMed, Cochrane library, Google Scholar and references of retrieved articles were used to search for articles. A standard data extraction approach was employed and presented using Preferred Reporting of Items for Systematic Reviews and Meta-Analyses. The Newcastle-Ottawa Scale quality assessment tool was used to evaluate the quality of studies. Analysis held using STATA V.11. The funnel plot and Egger's regression test were applied to check for the potential sources of bias. Heterogeneity among the studies was tested using I² statistics that have been calculated and compared with the standard. Meta-regression and subgroup analysis were done to identify the potential sources of heterogeneity. Estimation of blindness was carried out using Duval and Twee die's trim and fill analysis. The pooled prevalence of blindness in Ethiopia is found to be 1.18% (95% CI 0.650% to 1.706%). Blindness is among the main public health difficulties in Ethiopia. So, it demands up-to-date strategies and its implementation, preventive and curative eye care service with affordable and accessible interventions, and evidence-based advocacy. The trial Registration Number is CRD42021268448.

Identifiants

pubmed: 36161856
pii: bmjophth-2021-000949
doi: 10.1136/bmjophth-2021-000949
pmc: PMC9171275
pii:
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Ethiop Med J. 1997 Jan;35(1):43-51
pubmed: 9293146
Ethiop Med J. 2013 Apr;51(2):123-32
pubmed: 24079156
Cochrane Database Syst Rev. 2018 Feb 20;2:CD001054
pubmed: 29460275
PLoS One. 2021 Mar 22;16(3):e0248936
pubmed: 33750986
Ethiop Med J. 1995 Jul;33(3):163-74
pubmed: 7588655
Ethiop Med J. 2008 Jul;46(3):211-8
pubmed: 19271384
Disabil Rehabil. 2006 Aug 15;28(15):949-53
pubmed: 16861203
Trop Geogr Med. 1993;45(4):168-70
pubmed: 8236467
Ethiop J Health Sci. 2014 Oct;24(4):353-8
pubmed: 25489200
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234
pubmed: 29032195
Ophthalmic Epidemiol. 1997 Mar;4(1):19-26
pubmed: 9145412
J Ophthalmol. 2020 Mar 23;2020:9056097
pubmed: 32280539
BMC Ophthalmol. 2021 Feb 19;21(1):96
pubmed: 33607949
Ethiop J Health Sci. 2021 Jul;31(4):831-836
pubmed: 34703183
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Br J Ophthalmol. 2003 May;87(5):526-30
pubmed: 12714383
Clin Optom (Auckl). 2021 Mar 02;13:83-91
pubmed: 33688291
PLoS One. 2021 Aug 19;16(8):e0255369
pubmed: 34411104
Middle East Afr J Ophthalmol. 2012 Oct;19(4):372-6
pubmed: 23248538
Ethiop J Health Sci. 2014 Jul;24(3):227-34
pubmed: 25183929
Ethiop J Health Sci. 2014 Jan;24(1):69-74
pubmed: 24591801
PLoS One. 2021 Aug 13;16(8):e0256145
pubmed: 34388219
J Ophthalmol. 2020 May 28;2020:7042905
pubmed: 32566266
Clin Exp Optom. 2013 Jan;96(1):65-9
pubmed: 22784031
BMC Ophthalmol. 2020 Aug 3;20(1):316
pubmed: 32746798
BMC Infect Dis. 2019 Oct 24;19(1):886
pubmed: 31651236
Clin Optom (Auckl). 2021 Jul 20;13:201-208
pubmed: 34321948
Clin Ophthalmol. 2017 Nov 06;11:1941-1948
pubmed: 29184383
J Ophthalmol. 2020 Aug 22;2020:6934013
pubmed: 32908684
BMC Public Health. 2017 Oct 2;17(1):762
pubmed: 28969630
BMJ Glob Health. 2017 Jun 10;2(2):e000264
pubmed: 29225928
BMC Ophthalmol. 2018 Sep 3;18(1):232
pubmed: 30176841
Afr Health Sci. 2020 Mar;20(1):533-542
pubmed: 33402942
Afr J Disabil. 2020 Sep 16;9:657
pubmed: 33102185
Community Eye Health. 2020;33(110):S16-S17
pubmed: 34007122
Bull World Health Organ. 1995;73(1):115-21
pubmed: 7704921
Trop Geogr Med. 1992 Jan;44(1-2):135-41
pubmed: 1496706
SAGE Open Med. 2019 May 10;7:2050312119849769
pubmed: 31205693
BMC Ophthalmol. 2014 Jul 29;14:95
pubmed: 25070579
Bull World Health Organ. 2004 Nov;82(11):844-51
pubmed: 15640920
J Clin Epidemiol. 2001 Oct;54(10):1046-55
pubmed: 11576817
Br J Ophthalmol. 2003 Jun;87(6):677-80
pubmed: 12770959
East Afr Med J. 2008 Dec;85(12):593-6
pubmed: 19413215
Trans R Soc Trop Med Hyg. 2011 Sep;105(9):507-11
pubmed: 21621807
Ethiop J Health Sci. 2014 Jul;24(3):219-26
pubmed: 25183928
BMC Ophthalmol. 2020 May 4;20(1):176
pubmed: 32366285
Clin Optom (Auckl). 2016 Nov 21;8:85-91
pubmed: 30214353
BMC Ophthalmol. 2014 Apr 15;14:50
pubmed: 24731554
Clin Optom (Auckl). 2016 Dec 23;9:11-18
pubmed: 30214355
Br J Ophthalmol. 2016 Sep;100(9):1157-62
pubmed: 27267606
Clin Ophthalmol. 2020 Mar 11;14:767-774
pubmed: 32210530
Clin Optom (Auckl). 2019 Nov 08;11:135-143
pubmed: 31807106
J Ophthalmol. 2017;2017:9326108
pubmed: 28706737

Auteurs

Merkineh Markos (M)

Department of Public Health, College of Health Science, Woldia University, Woldia, Ethiopia markosmerkineh330@gmail.com.

Biruktayit Kefyalew (B)

Department of Ophthalmology and Optometry, Hawassa University, Hawassa, Ethiopia.

Hana Belay Tesfaye (HB)

Department of Early Childhood Care and Education, University of Gondar, Gondar, Ethiopia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH